Cardiology

Treat-to-target strategy in gout management is effective

Gout is the most common form of inflammatory arthritis, caused by crystallization of uric acid in the joint. Rheumatologists have long recommended that patients with gout be treated with drugs to lower uric acid in their ...

Arthritis & Rheumatism

Obstructive sleep apnea linked with higher risk of gout

New research reveals that people with obstructive sleep apnea (OSA) have a higher risk of developing gout, even beyond the first years after being diagnosed with the sleep disorder. The findings are published in Arthritis ...

Alzheimer's disease & dementia

Gout in the elderly linked to higher risk of dementia

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) suggest that gout is associated with a 17-20% higher risk of dementia in the elderly.

Diseases, Conditions, Syndromes

Major cardiovascular study of gout patients has unexpected finding

A large study of cardiovascular events in gout patients taking one of two medications to prevent excess build-up of uric acid has found that one of the drugs, febuxostat, increased the risk of death for those with heart disease, ...

Diabetes

Plasma volume changes may mediate effects of empagliflozin

(HealthDay)—The reduction in risk of cardiovascular (CV) death with empagliflozin is most mediated by changes in hematocrit and hemoglobin, according to research published online Dec. 4 in Diabetes Care.

Arthritis & Rheumatism

Anti-hypertension DASH diet may reduce the risk of gout

The results of a study led by Massachusetts General Hospital (MGH) investigators suggest that following a diet known to reduce the risk of hypertension and cardiovascular disease may also reduce the risk of gout. The team's ...

page 4 from 10